Associated Papers
Human inborn errors of the alternative NF-κB pathway.
Le Voyer T et al.
Journal of Human Immunity, 2026
Inflammatory bowel disease in a young female patient with a novel de novo TRAF3 frameshift variant responsive to ustekinumab: a case report.
Takeuchi I et al.
Intestinal Research, 2025
40181234 (PubMed )
Supplement: ir-2024-00190-Supplementary-Table-1.pdf
Heterozygous Predicted Loss-of-function Variants of TRAF3 in Patients with Common Variable Immunodeficiency.
Urban B et al.
Journal of Clinical Immunology, 2024
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.
Ansari-Pour N et al.
Blood, 2023
36223594 (PubMed )
Supplement: BLOOD_BLD-2022-017010-mmc2.xlsx › Supplementary_Table_S2
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations.
Rae W et al.
Science Immunology, 2022
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
Chow YP et al.
Scientific Reports, 2017
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population.
Jirabanditsakul C et al.
Technology in Cancer Research & Treatment, 0
Select a paper to view details